MCL

Due to the Memorial Day holiday (recognized on Monday, May 30), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please plan ahead.

For a young child diagnosed with inflammatory bowel disease, an unexpected turn of events led by results of a Mayo Clinic Laboratories test freed him and his family from the bonds of frequent medical visits and expensive treatment, and opened the door to a life unencumbered by illness.

In this month's "Hot Topic," Elitza Theel, Ph.D., will be discussing laboratory utilization management, specifically for diagnostic testing for tick-borne diseases.

This list includes updates posted to mayocliniclabs.com during the month of April.

Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. To better reflect this testing evolution, and to reduce confusion and improve utilization for our clients, effective April 28, we are renaming our phenotype-specific evaluations.

Justin Kreuter, M.D., sits down with Curt Hanson, M.D., professor of Laboratory Medicine and Pathology, a hematopathology consultant at Mayo Clinic, and executive vice president and chief medical officer for Mayo Collaborative Services, to celebrate Lab Week 2022 and discuss why it’s important to look at our past when planning for the future.

Joel Cayou’s goal as a supervisor in Specimen Handling is to support his staff wherever he can in the vital work they do to keep Mayo Clinic Laboratories’ operations running efficiently.

Mayo Clinic recently announced plans to invest in an expansion project to enhance laboratory medicine. The expansion project will support Mayo Clinic Laboratories' goal to provide diagnostics to Mayo Clinic patients throughout the nation and abroad. Health care teams around the world will have access to laboratory testing through Mayo Clinic Laboratories' Test Catalog, and Mayo Clinic patients will have access to testing via their Mayo Clinic health care providers.  

In this test specific episode of the  "Answers From the Lab" podcast, Melissa Snyder, Ph.D., explains how IBDP2, when used after first-line testing has failed, can distinguish between ulcerative colitis and Crohn’s disease.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Mayo Clinic Laboratories’ manager of Outreach and Network Support, Jane Hermansen, to celebrate laboratory successes from the past and look toward the future.

The considerations physicians must weigh when evaluating suspected neuropathy patients with special emphasis put on small-fiber neuropathy and the most appropriate laboratory testing related to that phenotype.

Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate a malfunctioning metal hip implant. A Mayo Clinic study found that synovial fluid testing for those elements is more sensitive than serum or whole blood testing.

Ann Moyer, M.D., Ph.D., discusses TPNUQ, Mayo Clinic Laboratories' genotyping test for identifying patients at risk for thiopurine toxicity. Used prior to therapy initiation, our assay evaluates for nuances in both TPMT and NUDT15, which have associations to thiopurine metabolization.